Fang-Ming Chen

5PUBLICATIONS
51CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 03, 2026
Development of a Nomogram-Based Clinical Estimation Model for Pathological Upstaging in Patients With Preoperative Ductal Carcinoma In Situ.

|Jul 06, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|Mar 25, 2022
Correction: Kao et al. RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655.

Chieh-Ni Kao, Sin-Hua Moi, Ming-Feng Hou

|Aug 06, 2021
RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer.

Chieh-Ni Kao, Sin-Hua Moi, Ming-Feng Hou

|Jul 01, 2020
Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer.

Fang-Ming Chen, Li-Ju Huang, Fu Ou-Yang

Pageof 1

Frequent Collaborators

3 joint publications

Ming-Feng Hou

2 joint publications

Sin-Hua Moi

2 joint publications

Chi-Wen Luo

2 joint publications

Mei-Ren Pan